General Information of the Protein
Protein ID
PT01357
Protein Name
Histamine H2 receptor
Secondarily
Protein Name
Gastric receptor I
Gene Name
HRH2
Sequence
MAPNGTASSFCLDSTACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCFIVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRYPVLVTPVRVAISLVLIWVISITLSFLSIHLGWNSRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLPLLIMCITYYRIFKVARDQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEVLEAIVLWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRSNASQLSRTQSREPRQQEEKPLKLQVWSGTEVTAPQGATDR
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Small molecule receptor (family A GPCR)
>
Monoamine receptor
>
Histamine receptor
Function
The H2 subclass of histamine receptors mediates gastric acid secretion. Also appears to regulate gastrointestinal motility and intestinal secretion. Possible role in regulating cell growth and differentiation. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase and, through a separate G protein-dependent mechanism, the phosphoinositide/protein kinase (PKC) signaling pathway (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
P25021

Secondarily ID:
B5BUP7
Q14464
Q7Z5R9
    Show/Hide
Ensembl ID
ENSG00000113749
HGNC ID
HGNC:5183
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000901 , 661W
Compound ID Compound Name Compound Formula
CP0387083
(3aS,9bS)-3a-methyl-5-phenyl-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline
   Show/Hide
C18H20N2
 1
1
Ki = 1995.26 nM
   TI
   LI
   LO
   TS
CP0391120
(1S,2R)-1-ethyl-7-methoxy-2-methyl-3,4-dihydro-1H-naphthalen-2-amine
   Show/Hide
C14H21NO
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CP0391121
(3S,4S)-4-ethyl-3,6-dimethyl-2,4-dihydrochromen-3-amine
   Show/Hide
C13H19NO
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CP0391154
(3aS,9bS)-7,9-dimethoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole
   Show/Hide
C14H19NO3
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CP0411059
(3S,4S)-4-ethyl-3-methyl-1-phenyl-2,4-dihydroquinolin-3-amine
   Show/Hide
C18H22N2
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0036920
2-(1H-imidazol-4-yl)ethan-1-amine
   Show/Hide
C5H9N3
 2
1 EC50 = 463 nM
2 Ki = 5000 nM
CP0035927
(Cimetidine) N-Methyl-N''''-[2-(5-methyl-1H-imidazol-4-ylmethylsulfanyl)-ethyl]-guanidine,cyanide
   Show/Hide
C10H16N6S
 6
1 IC50 = 140 nM
2 IC50 = 180 nM
3 IC50 = 270 nM
4 IC50 = 781 nM
5 Ki = 140 nM
6 Ki = 170 nM
CP0057002
1-[4-(1H-imidazol-5-yl)butyl]-3-methylthiourea
   Show/Hide
C9H16N4S
 1
1 Kd = 7800 nM
CP0092861
2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole
   Show/Hide
C15H20N2S
 1
1 Ki > 1000 nM
Clinical Information about the Protein
Target 1 ( Histamine H2 receptor (H2R) )
Target Type Successful Target
Disease 4 Target-related Diseases  4
1 Gastric secretory disorder [ICD-11: DD90]
2 Acid-reflux disorder [ICD-11: DA22]
3 Peptic ulcer [ICD-11: DA61]
4 Duodenal ulcer [ICD-11: DA63]
Approved Drug(s) 5 Approved Drugs  5
1 Betazole Approved
Gastric secretory disorder
2 Cimetidine Approved
Acid-reflux disorder
3 Famotidine Approved
Peptic ulcer
4 Nizatidine Approved
Acid-reflux disorder
5 Ranitidine Approved
Peptic ulcer
Discontinued Drug(s) 1 Discontinued Drug  1
1 KU-1257 Discontinued in Phase 3
Duodenal ulcer